Trade Alert: The Chief Scientific Officer Of Sage Therapeutics, Inc. (NASDAQ:SAGE), Albert Robichaud, Has Just Spent US$1.6m Buying Shares
Sage Therapeutics, Inc. (NASDAQ:SAGE) shareholders (or potential shareholders) will be happy to see that the Chief… …read more […]
